This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/mesh/concept/
n10http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB04485/identifier/chebi/
admshttp://www.w3.org/ns/adms#
n19http://linked.opendata.cz/resource/drugbank/drug/DB04485/identifier/wikipedia/
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n18http://linked.opendata.cz/resource/drugbank/drug/DB04485/identifier/pdb/
n17http://linked.opendata.cz/resource/drugbank/drug/DB04485/identifier/kegg-compound/
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/mesh/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04485/identifier/bindingdb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB04485/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n16http://linked.opendata.cz/resource/drugbank/drug/DB04485/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04485/identifier/drugbank/

Statements

Subject Item
n2:DB04485
rdf:type
n5:Drug
n5:description
Deoxythymidine is a pyrimidine deoxynucleoside. Deoxythymidine is the DNA nucleoside T, which pairs with deoxyadenosine (A) in double-stranded DNA. In cell biology it is used to synchronize the cells in S phase.
n5:group
experimental
owl:sameAs
n8:DB04485 n10:DB04485
dcterms:title
Deoxythymidine
adms:identifier
n12:17748 n13:DB04485 n14:1 n15:3000346 n16:46507598 n17:C00214 n18:THM n19:Thymidine
n5:synonym
thymine deoxyriboside deoxyribosylthymine 2'-Deoxythymidine Thymidine
n5:synthesisReference
Jeffrey D. Wilson, "Preparation of 3'azido-3-'-deoxythymidine." U.S. Patent US4921950, issued October, 1986.
n3:hasConcept
n4:M0021447
n5:IUPAC-Name
n6:271B5E56-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5E5C-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5E5B-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5E58-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5E59-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5E5A-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5E54-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5E52-363D-11E5-9242-09173F13E4C5 n6:271B5E6D-363D-11E5-9242-09173F13E4C5 n6:271B5E55-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5E53-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5E62-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5E63-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5E5D-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5E5E-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5E60-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5E5F-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5E61-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
50-89-5
n5:Bioavailability
n6:271B5E68-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5E6A-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5E6B-363D-11E5-9242-09173F13E4C5
n5:Melting-Point
n6:271B5E6C-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5E67-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5E66-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5E69-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5E57-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5E64-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5E65-363D-11E5-9242-09173F13E4C5